Click a link below to view the mailing archive as if it had been sent to you.
| 2012-03-31 00:00 | | ImmunoGen Rises After Drug Delays Cancer Worsening in Study and more... |
| 2012-03-30 12:00 | | For Illumina, Roche's Third Offer Not So Charming and more... |
| 2012-03-30 00:00 | | MAP Pharma falls on 4Q loss and restatement and more... |
| 2012-03-29 12:00 | | Watson Said to Be in Talks to Buy Swiss Drugmaker Actavis and more... |
| 2012-03-29 00:00 | | FDA adds warnings to Forest Labs' Celexa label and more... |
| 2012-03-28 12:00 | | Is a Pfizer Breakup in the Cards? How Much Would it be Worth? and more... |
| 2012-03-27 12:00 | | Biogen executive team rakes in millions from its 2011 successes and more... |
| 2012-03-27 00:00 | | Is Pfizer Pfinished? and more... |
| 2012-03-26 12:00 | | Teva announces FDA approval of QNASL and more... |
| 2012-03-26 00:00 | | 20 Biotech Stocks Being Bought Up By Hedge Funds |
| 2012-03-25 00:00 | | OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters and more... |
| 2012-03-24 12:00 | | Merck Blood Thinner Stops Heart Attacks With Risk of Bleeding and more... |
| 2012-03-24 00:00 | | Positive FDA Recommendation For Drug Good New For Tekmira and more... |
| 2012-03-23 12:00 | | Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin and more... |
| 2012-03-23 00:00 | | Obesity And The FDA: Why Qnexa Is Generating Buzz and more... |
| 2012-03-22 12:00 | | Advisory Panel Pans Drug, Investors Shrug? and more... |
| 2012-03-22 00:00 | | Pharma sales execs: Current model is broken; changes are coming and more... |
| 2012-03-21 12:00 | | J&J Unit Closes Facebook Page Due To Comments and more... |
| 2012-03-21 00:00 | | EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data |
| 2012-03-20 12:00 | | 3 Hot Pharmas With Skin In The Game and more... |
| 2012-03-19 12:00 | | Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs? and more... |
| 2012-03-19 00:00 | | China Biotech In Review: Cloud Hangs Over Pharmaceutical Industry Over Cost-Cutting and more... |
| 2012-03-18 12:00 | | Biotechs Have No Business in This Indication and more... |
| 2012-03-18 00:00 | | Some Healthy Respect for Novartis, Please and more... |
| 2012-03-17 12:00 | | For Biotech Firms, Gravy Days Are Over and more... |
| 2012-03-17 00:00 | | What Stresses Some Pharma Employees The Most and more... |
| 2012-03-16 12:00 | | FDA Staff Questions Benefits of Glaxo, Merck Cancer Drugs and more... |
| 2012-03-15 12:00 | | United Therapeutics sues Sandoz over hypertension drug and more... |
| 2012-03-15 00:00 | | Pharma Sales Spending Shrinks Again and more... |
| 2012-03-14 12:00 | | 7 Cancer Drug Stocks to Know Right Now and more... |
| 2012-03-14 00:00 | | NicOx Shares Gain on Glaucoma Drug Study Results |
| 2012-03-13 12:00 | | Can Statins Prevent Parkinson's Disease? and more... |
| 2012-03-13 00:00 | | Arena Pharma's 5-Year Revenue Forecast and more... |
| 2012-03-12 12:00 | | Oncothyreon At $5: Buy Time Or Sign Of Trouble? and more... |
| 2012-03-12 00:00 | | Good News For Alnylam: PBL Making Baulcombe Patent Widely Available and more... |
| 2012-03-11 00:00 | | Teva's ProAir HFA with dose counter receives US FDA approval and more... |
| 2012-03-10 00:00 | | Aastrom Raises Cash To Fund Pivotal Trial and more... |
| 2012-03-09 12:00 | | Speculative Biotech For The Iron-Stomached and more... |
| 2012-03-09 00:00 | | Bellicum snags $20M for mid-stage cancer vaccine program and more... |
| 2012-03-08 12:00 | | J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation and more... |
| 2012-03-08 00:00 | | GileadâÔö£é?öé??Ôö£é?ö?ñós Experimental 4-in-1 AIDS Pill Effective as Current Drug in Study and more... |
| 2012-03-07 12:00 | | GlaxoSmithKline resumes search for consumer drugs buyer, Reuters says and more... |
| 2012-03-06 12:00 | | Emergent BioSolutions Earnings Preview and more... |
| 2012-03-06 00:00 | | Biogen And Samsung Advance Biosimilars Venture and more... |
| 2012-03-05 12:00 | | 10 Biotechs Targeting Cancer Stem Cell Destruction and more... |
| 2012-03-05 00:00 | | Johnson & Johnson Could Double In 5 Years and more... |
| 2012-03-04 00:00 | | Actos Bladder Cancer Lawsuits to See First Hearing, Kershaw, Cutter & Ratinoff Reports and more... |
| 2012-03-02 12:00 | | 4 Small-Cap, High-Risk, High-Reward Bio-Pharmas and more... |
| 2012-03-02 00:00 | | Judge refuses to halt Amgen-Micromet deal and more... |
| 2012-03-01 12:00 | | Pfizer and Bristol-MyersâÔö£é?öé??Ôö£é?ö?ñó Blood Thinner Delayed by FDA and more... |
| 2012-03-01 00:00 | | Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March and more... |
